CC BY 4.0 · Neuropediatrics 2020; 51(05): 315-335
DOI: 10.1055/s-0040-1701658
Review Article

ADHD: Current Concepts and Treatments in Children and Adolescents

Renate Drechsler
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
,
Silvia Brem
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
2   Neuroscience Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich, Switzerland
,
Daniel Brandeis
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
2   Neuroscience Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich, Switzerland
3   Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
4   Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
,
Edna Grünblatt
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
2   Neuroscience Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich, Switzerland
4   Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
,
Gregor Berger
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
,
1   Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
2   Neuroscience Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich, Switzerland
4   Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
› Author Affiliations

Abstract

Attention deficit hyperactivity disorder (ADHD) is among the most frequent disorders within child and adolescent psychiatry, with a prevalence of over 5%. Nosological systems, such as the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) and the International Classification of Diseases, editions 10 and 11 (ICD-10/11) continue to define ADHD according to behavioral criteria, based on observation and on informant reports. Despite an overwhelming body of research on ADHD over the last 10 to 20 years, valid neurobiological markers or other objective criteria that may lead to unequivocal diagnostic classification are still lacking. On the contrary, the concept of ADHD seems to have become broader and more heterogeneous. Thus, the diagnosis and treatment of ADHD are still challenging for clinicians, necessitating increased reliance on their expertise and experience. The first part of this review presents an overview of the current definitions of the disorder (DSM-5, ICD-10/11). Furthermore, it discusses more controversial aspects of the construct of ADHD, including the dimensional versus categorical approach, alternative ADHD constructs, and aspects pertaining to epidemiology and prevalence. The second part focuses on comorbidities, on the difficulty of distinguishing between “primary” and “secondary” ADHD for purposes of differential diagnosis, and on clinical diagnostic procedures. In the third and most prominent part, an overview of current neurobiological concepts of ADHD is given, including neuropsychological and neurophysiological researches and summaries of current neuroimaging and genetic studies. Finally, treatment options are reviewed, including a discussion of multimodal, pharmacological, and nonpharmacological interventions and their evidence base.



Publication History

Received: 12 August 2019

Accepted: 28 November 2019

Article published online:
19 June 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition DSM-5TM. Washington, DC: American Psychiatric Publishing; 2013
  • 2 World Health Organization. ICD-11 for mortality and morbidity statistics. Available at: https://icd.who.int/browse11/l-m/en . Accessed May 18, 2019
  • 3 World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th Revision.. Vol., 2.. Geneva: World Health Organization; 2004
  • 4 Willcutt EG, Nigg JT, Pennington BF. , et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol 2012; 121 (04) 991-1010
  • 5 Ward MF, Wender PH, Reimherr FW. The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150 (06) 885-890
  • 6 Baytunca MB, Inci SB, Ipci M, Kardas B, Bolat GU, Ercan ES. The neurocognitive nature of children with ADHD comorbid sluggish cognitive tempo: Might SCT be a disorder of vigilance?. Psychiatry Res 2018; 270: 967-973
  • 7 Saxbe C, Barkley RA. The second attention disorder? Sluggish cognitive tempo vs. attention-deficit/hyperactivity disorder: update for clinicians. J Psychiatr Pract 2014; 20 (01) 38-49
  • 8 Willcutt EG, Chhabildas N, Kinnear M. , et al. The internal and external validity of sluggish cognitive tempo and its relation with DSM-IV ADHD. J Abnorm Child Psychol 2014; 42 (01) 21-35
  • 9 Becker SP, Leopold DR, Burns GL. , et al. The internal, external, and diagnostic validity of sluggish cognitive tempo: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 2016; 55 (03) 163-178
  • 10 Mueller AK, Tucha L, Koerts J, Groen Y, Lange KW, Tucha O. Sluggish cognitive tempo and its neurocognitive, social and emotive correlates: a systematic review of the current literature. J Mol Psychiatry 2014; 2 (01) 5
  • 11 Brotman MA, Kircanski K, Leibenluft E. Irritability in children and adolescents. Annu Rev Clin Psychol 2017; 13: 317-341
  • 12 Faraone SV, Rostain AL, Blader J. , et al. Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention. J Child Psychol Psychiatry 2019; 60 (02) 133-150
  • 13 Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry 2014; 171 (03) 276-293
  • 14 Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. New York: Oxford University Press; 1995
  • 15 Hirsch O, Chavanon M, Riechmann E, Christiansen H. Emotional dysregulation is a primary symptom in adult attention-deficit/hyperactivity disorder (ADHD). J Affect Disord 2018; 232: 41-47
  • 16 Balázs J, Keresztény A. Subthreshold attention deficit hyperactivity in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 2014; 23 (06) 393-408
  • 17 Das D, Cherbuin N, Anstey KJ, Easteal S. ADHD symptoms and cognitive abilities in the midlife cohort of the PATH through life study. J Atten Disord 2015; 19 (05) 414-424
  • 18 Norén Selinus E, Molero Y, Lichtenstein P. , et al. Subthreshold and threshold attention deficit hyperactivity disorder symptoms in childhood: psychosocial outcomes in adolescence in boys and girls. Acta Psychiatr Scand 2016; 134 (06) 533-545
  • 19 Larsson H, Anckarsater H, Råstam M, Chang Z, Lichtenstein P. Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry 2012; 53 (01) 73-80
  • 20 Biederman J, Fitzgerald M, Kirova AM, Woodworth KY, Biederman I, Faraone SV. Further Evidence of Morbidity and Dysfunction Associated With Subsyndromal ADHD in Clinically Referred Children. J Clin Psychiatry 2018; 79 (05) 17m11870
  • 21 Gomez R, Corr PJ. ADHD and personality: a meta-analytic review. Clin Psychol Rev 2014; 34 (05) 376-388
  • 22 Martel MM, Nigg JT. Child ADHD and personality/temperament traits of reactive and effortful control, resiliency, and emotionality. J Child Psychol Psychiatry 2006; 47 (11) 1175-1183
  • 23 Martel MM, Nigg JT, von Eye A. How do trait dimensions map onto ADHD symptom domains?. J Abnorm Child Psychol 2009; 37 (03) 337-348
  • 24 Nigg JT. Temperament and developmental psychopathology. J Child Psychol Psychiatry 2006; 47 (3,4): 395-422
  • 25 Rothbart MK. Becoming who we are: Temperament and Personality in Development. New York: Guilford Press; 2011
  • 26 Rothbart MK, Derryberry D. Development of individual differences in temperament. In: Lamb ME, Brown AL. , eds. Advances in Developmental Psychology. New York, NY: Lawrence Erlbaum Associates; 1981: 37-86
  • 27 Drechsler R, Zulauf Logoz M, Walitza S, Steinhausen HC. The relations between temperament, character, and executive functions in children with ADHD and clinical controls. J Atten Disord 2018; 22 (08) 764-775
  • 28 Einziger T, Levi L, Zilberman-Hayun Y. , et al. Predicting ADHD symptoms in adolescence from early childhood temperament traits. J Abnorm Child Psychol 2018; 46 (02) 265-276
  • 29 Karalunas SL, Fair D, Musser ED, Aykes K, Iyer SP, Nigg JT. Subtyping attention-deficit/hyperactivity disorder using temperament dimensions: toward biologically based nosologic criteria. JAMA Psychiatry 2014; 71 (09) 1015-1024
  • 30 Karalunas SL, Gustafsson HC, Fair D, Musser ED, Nigg JT. Do we need an irritable subtype of ADHD? Replication and extension of a promising temperament profile approach to ADHD subtyping. Psychol Assess 2019; 31 (02) 236-247
  • 31 Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 2015; 56 (03) 345-365
  • 32 Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014; 43 (02) 434-442
  • 33 Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164 (06) 942-948
  • 34 Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 2015; 135 (04) e994-e1001
  • 35 Bachmann CJ, Philipsen A, Hoffmann F. ADHD in Germany: trends in diagnosis and pharmacotherapy. Dtsch Arztebl Int 2017; 114 (09) 141-148
  • 36 Fayyad J, Sampson NA, Hwang I. , et al; WHO World Mental Health Survey Collaborators. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord 2017; 9 (01) 47-65
  • 37 Sayal K, Prasad V, Daley D, Ford T, Coghill D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018; 5 (02) 175-186
  • 38 Taylor E. Attention deficit hyperactivity disorder: overdiagnosed or diagnoses missed?. Arch Dis Child 2017; 102 (04) 376-379
  • 39 Song M, Dieckmann NF, Nigg JT. Addressing discrepancies between ADHD prevalence and case identification estimates among U.S. children utilizing NSCH 2007-2012. J Atten Disord 2019; 23 (14) 1691-1702
  • 40 Xu G, Strathearn L, Liu B, Yang B, Bao W. Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997-2016. JAMA Netw Open 2018; 1 (04) e181471
  • 41 Mohr Jensen C, Steinhausen HC. Time trends in incidence rates of diagnosed attention-deficit/hyperactivity disorder across 16 years in a nationwide Danish registry study. J Clin Psychiatry 2015; 76 (03) e334-e341
  • 42 Steinhausen HC, Döpfner M, Schubert I. [Time trends in the frequencies of ADHD and stimulant medication]. Z Kinder Jugendpsychiatr Psychother 2016; 44 (04) 275-284
  • 43 Raman SR, Man KKC, Bahmanyar S. , et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 2018; 5 (10) 824-835
  • 44 Bachmann CJ, Wijlaars LP, Kalverdijk LJ. , et al. Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012. Eur Neuropsychopharmacol 2017; 27 (05) 484-493
  • 45 Beau-Lejdstrom R, Douglas I, Evans SJ, Smeeth L. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open 2016; 6 (06) e010508
  • 46 Piper BJ, Ogden CL, Simoyan OM. , et al. Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS One 2018; 13 (11) e0206100
  • 47 DuPaul GJ, Gormley MJ, Laracy SD. Comorbidity of LD and ADHD: implications of DSM-5 for assessment and treatment. J Learn Disabil 2013; 46 (01) 43-51
  • 48 Abdallah MW, Greaves-Lord K, Grove J, Nørgaard-Pedersen B, Hougaard DM, Mortensen EL. Psychiatric comorbidities in autism spectrum disorders: findings from a Danish Historic Birth Cohort. Eur Child Adolesc Psychiatry 2011; 20 (11–12): 599-601
  • 49 Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47 (08) 921-929
  • 50 Rothenberger A, Becker A, Brüni LG, Roessner V. Influence of tics and/or obsessive compulsive behaviour on the phenomenology of coexistent ADHD. In: Banaschewski T, Coghill D, Zuddas A. , eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford: Oxford University Press; 2018: 247-253
  • 51 Goulardins JB, Rigoli D, Licari M. , et al. Attention deficit hyperactivity disorder and developmental coordination disorder: Two separate disorders or do they share a common etiology. Behav Brain Res 2015; 292: 484-492
  • 52 Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry 1999; 40 (01) 57-87
  • 53 Meinzer MC, Pettit JW, Viswesvaran C. The co-occurrence of attention-deficit/hyperactivity disorder and unipolar depression in children and adolescents: a meta-analytic review. Clin Psychol Rev 2014; 34 (08) 595-607
  • 54 Barkley RA. ADHD and the Nature of Self-Control. New York, NY: Guilford Press; 2005
  • 55 Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011; 50 (01) 9-21
  • 56 Enagandula R, Singh S, Adgaonkar GW, Subramanyam AA, Kamath RM. Study of Internet addiction in children with attention-deficit hyperactivity disorder and normal control. Ind Psychiatry J 2018; 27 (01) 110-114
  • 57 Aguirre Castaneda RL, Kumar S, Voigt RG. , et al. Childhood attention-deficit/hyperactivity disorder, sex, and obesity: a longitudinal population-based study. Mayo Clin Proc 2016; 91 (03) 352-361
  • 58 Cortese S, Tessari L. Attention-deficit/hyperactivity disorder (ADHD) and obesity: update 2016. Curr Psychiatry Rep 2017; 19 (01) 4
  • 59 Nigg JT, Johnstone JM, Musser ED, Long HG, Willoughby MT, Shannon J. Attention-deficit/hyperactivity disorder (ADHD) and being overweight/obesity: New data and meta-analysis. Clin Psychol Rev 2016; 43: 67-79
  • 60 Elia J, Takeda T, Deberardinis R. , et al. Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorder. J Pediatr 2009; 155 (02) 239-44.e5
  • 61 Tsai MH, Hsu JF, Huang YS. Sleep problems in children with attention deficit/hyperactivity disorder: current status of knowledge and appropriate management. Curr Psychiatry Rep 2016; 18 (08) 76
  • 62 Arruda MA, Arruda R, Guidetti V, Bigal ME. ADHD Is Comorbid to Migraine in Childhood: A Population-Based Study. J Atten Disord 2017; ; (e-pub ahead of print) DOI: 10.1177/1087054717710767:1087054717710767.
  • 63 Fluegge K, Fluegge K. ADHD and comorbid migraine. Epilepsy Behav 2018; 80: 378-379
  • 64 Kutuk MO, Tufan AE, Guler G. , et al. Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers. Brain Dev 2018; 40 (10) 857-864
  • 65 Brikell I, Ghirardi L, D'Onofrio BM. , et al. Familial liability to epilepsy and attention-deficit/hyperactivity disorder: a nationwide cohort study. Biol Psychiatry 2018; 83 (02) 173-180
  • 66 Socanski D, Aurlien D, Herigstad A, Thomsen PH, Larsen TK. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD). Seizure 2013; 22 (08) 651-655
  • 67 Willcutt EG, Pennington BF, Olson RK, Chhabildas N, Hulslander J. Neuropsychological analyses of comorbidity between reading disability and attention deficit hyperactivity disorder: in search of the common deficit. Dev Neuropsychol 2005; 27 (01) 35-78
  • 68 Willcutt EG. ADHD and reading disorder. In: Banaschewski T, Coghill D, Zuddas A. , eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford: Oxford University Press; 2018: 273-279
  • 69 Dekker MC, Koot HM. DSM-IV disorders in children with borderline to moderate intellectual disability. I: prevalence and impact. J Am Acad Child Adolesc Psychiatry 2003; 42 (08) 915-922
  • 70 Hässler F, Thome J. [Mental retardation and ADHD]. Z Kinder Jugendpsychiatr Psychother 2012; 40 (02) 83-93 , quiz 93–94
  • 71 Green T, Naylor PE, Davies W. Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies. J Neurodev Disord 2017; 9: 25
  • 72 Auvin S, Wirrell E, Donald KA. , et al. Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission. Epilepsia 2018; 59 (10) 1867-1880
  • 73 Williams AE, Giust JM, Kronenberger WG, Dunn DW. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat 2016; 12: 287-296
  • 74 Banerji A, Shah C. Ten-year experience of fetal alcohol spectrum disorder; diagnostic and resource challenges in Indigenous children. Paediatr Child Health 2017; 22 (03) 143-147
  • 75 Hirabaru K, Matsuo M. Neurological comorbidity in children with neurofibromatosis type 1. Pediatr Int (Roma) 2018; 60 (01) 70-75
  • 76 Franz AP, Bolat GU, Bolat H. , et al. Attention-deficit/hyperactivity disorder and very preterm/very low birth weight: a meta-analysis. Pediatrics 2018; 141 (01) 141
  • 77 Coghill D, Danckaerts M. Organizing and delivering treatment for ADHD. In: Banaschewski T, Coghill D, Zuddas A. , eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford: Oxford University Press; 2018: 417-425
  • 78 Pearl PL, Weiss RE, Stein MA. Medical mimics. Medical and neurological conditions simulating ADHD. Ann N Y Acad Sci 2001; 931: 97-112
  • 79 Donfrancesco R, Di Trani M, Andriola E. , et al. Bipolar disorder in children with adhd: a clinical sample study. J Atten Disord 2017; 21 (09) 715-720
  • 80 Caplan R, Siddarth P, Stahl L. , et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008; 49 (11) 1838-1846
  • 81 Kim EH, Yum MS, Kim HW, Ko TS. Attention-deficit/hyperactivity disorder and attention impairment in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2014; 37: 54-58
  • 82 Danhofer P, Pejčochová J, Dušek L, Rektor I, Ošlejšková H. The influence of EEG-detected nocturnal centrotemporal discharges on the expression of core symptoms of ADHD in children with benign childhood epilepsy with centrotemporal spikes (BCECTS): A prospective study in a tertiary referral center. Epilepsy Behav 2018; 79: 75-81
  • 83 Franke B, Michelini G, Asherson P. , et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol 2018; 28 (10) 1059-1088
  • 84 Ekinci O, Okuyaz Ç, Erdoğan S. , et al. Attention-deficit hyperactivity disorder (ADHD) in epilepsy and primary ADHD: differences in symptom dimensions and quality of life. J Child Neurol 2017; 32 (14) 1083-1091
  • 85 Romanos M, Schwenck C, Walitza S. [Diagnosis of attention-deficit hyperactivity disorder in childhood and adolescence]. Nervenarzt 2008; 79 (07) 782-790
  • 86 James SN, Rommel AS, Cheung C. , et al. Association of preterm birth with ADHD-like cognitive impairments and additional subtle impairments in attention and arousal malleability. Psychol Med 2018; 48 (09) 1484-1493
  • 87 Max JE, Schachar RJ, Levin HS. , et al. Predictors of secondary attention-deficit/hyperactivity disorder in children and adolescents 6 to 24 months after traumatic brain injury. J Am Acad Child Adolesc Psychiatry 2005; 44 (10) 1041-1049
  • 88 Haarbauer-Krupa J, Lee AH, Bitsko RH, Zhang X, Kresnow-Sedacca MJ. Prevalence of parent-reported traumatic brain injury in children and associated health conditions. JAMA Pediatr 2018; 172 (11) 1078-1086
  • 89 Liou YJ, Wei HT, Chen MH. , et al. Risk of traumatic brain injury among children, adolescents, and young adults with attention-deficit hyperactivity disorder in Taiwan. J Adolesc Health 2018; 63 (02) 233-238
  • 90 Salinas CM, Dean P, LoGalbo A, Dougherty M, Field M, Webbe FM. Attention-deficit hyperactivity disorder status and baseline neurocognitive performance in high school athletes. Appl Neuropsychol Child 2016; 5 (04) 264-272
  • 91 Ornstein TJ, Sagar S, Schachar RJ. , et al. Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury. J Int Neuropsychol Soc 2014; 20 (10) 971-981
  • 92 Kaufman J, Birmaher B, Brent D. , et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36 (07) 980-988
  • 93 Kaufman J, Birmaher B, Axelson D, Perepletchikova F, Brent D, Ryan N. K-SADS-PL DSM-5. Pittsburgh: Western Psychiatric Institute and Clinic; 2016
  • 94 Conners CK, Pitkanen J, Rzepa SR. Conners 3rd Edition (Conners 3; Conners 2008). In: Kreutzer JS, DeLuca J, Caplan B. , eds. Encyclopedia of Clinical Neuropsychology. New York, NY: Springer New York; 2011: 675-678
  • 95 Goodman R. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 1997; 38 (05) 581-586
  • 96 ADHS bei Kindern, Jugend und Erwachsenenalter. 2017 Available at: https://www.awmf.org/leitlinien/detail/ll/028-045.html . Accessed February 18, 2019
  • 97 National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management (NICE Guideline 87). 2018 Available at: https://www.nice.org.uk/guidance/ng87 . Accessed February 18, 2019
  • 98 Layton TJ, Barnett ML, Hicks TR, Jena AB. Attention deficit-hyperactivity disorder and month of school enrollment. N Engl J Med 2018; 379 (22) 2122-2130
  • 99 Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 2006; 10 (03) 117-123
  • 100 Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3 (08) 617-628
  • 101 Sonuga-Barke EJ. Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition. Behav Brain Res 2002; 130 (1,2): 29-36
  • 102 Petrovic P, Castellanos FX. Top-Down Dysregulation-From ADHD to Emotional Instability. Front Behav Neurosci 2016; 10: 70
  • 103 Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49 (04) 345-355
  • 104 Coghill DR, Seth S, Matthews K. A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models. Psychol Med 2014; 44 (09) 1989-2001
  • 105 Lambek R, Sonuga-Barke E, Tannock R, Sørensen AV, Damm D, Thomsen PH. Are there distinct cognitive and motivational sub-groups of children with ADHD?. Psychol Med 2018; 48 (10) 1722-1730
  • 106 Gomez R, Gomez RM, Winther J, Vance A. Latent profile analysis of working memory performance in a sample of children with ADHD. J Abnorm Child Psychol 2014; 42 (08) 1367-1379
  • 107 Roberts BA, Martel MM, Nigg JT. Are there executive dysfunction subtypes within ADHD?. J Atten Disord 2017; 21 (04) 284-293
  • 108 Fair DA, Bathula D, Nikolas MA, Nigg JT. Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc Natl Acad Sci U S A 2012; 109 (17) 6769-6774
  • 109 van Hulst BM, de Zeeuw P, Durston S. Distinct neuropsychological profiles within ADHD: a latent class analysis of cognitive control, reward sensitivity and timing. Psychol Med 2015; 45 (04) 735-745
  • 110 Bergwerff CE, Luman M, Weeda WD, Oosterlaan J. Neurocognitive profiles in children with ADHD and their predictive value for functional outcomes. J Atten Disord 2017; ; (e-pub ahead of print) DOI: 10.1177/1087054716688533:1087054716688533.
  • 111 Pievsky MA, McGrath RE. The neurocognitive profile of attention-deficit/hyperactivity disorder: a review of meta-analyses. Arch Clin Neuropsychol 2018; 33 (02) 143-157
  • 112 Romanos M, Renner TJ, Schecklmann M. , et al. Improved odor sensitivity in attention-deficit/hyperactivity disorder. Biol Psychiatry 2008; 64 (11) 938-940
  • 113 Little LM, Dean E, Tomchek S, Dunn W. Sensory processing patterns in autism, attention deficit hyperactivity disorder, and typical development. Phys Occup Ther Pediatr 2018; 38 (03) 243-254
  • 114 Banaschewski T, Ruppert S, Tannock R. , et al. Colour perception in ADHD. J Child Psychol Psychiatry 2006; 47 (06) 568-572
  • 115 Fuermaier ABM, Hüpen P, De Vries SM. , et al. Perception in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord 2018; 10 (01) 21-47
  • 116 Da Fonseca D, Seguier V, Santos A, Poinso F, Deruelle C. Emotion understanding in children with ADHD. Child Psychiatry Hum Dev 2009; 40 (01) 111-121
  • 117 Marton I, Wiener J, Rogers M, Moore C, Tannock R. Empathy and social perspective taking in children with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol 2009; 37 (01) 107-118
  • 118 Korrel H, Mueller KL, Silk T, Anderson V, Sciberras E. Research review: language problems in children with attention-deficit hyperactivity disorder - a systematic meta-analytic review. J Child Psychol Psychiatry 2017; 58 (06) 640-654
  • 119 Rhodes SM, Park J, Seth S, Coghill DR. A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder. J Child Psychol Psychiatry 2012; 53 (02) 128-137
  • 120 Egeland J, Johansen SN, Ueland T. Do low-effort learning strategies mediate impaired memory in ADHD?. J Learn Disabil 2010; 43 (05) 430-440
  • 121 Lange-Malecki B, Treue S, Rothenberger A, Albrecht B. Cognitive control over visual motion processing - are children with adhd especially compromised? a pilot study of flanker task event-related potentials. Front Hum Neurosci 2018; 12: 491
  • 122 Wells EL, Day TN, Harmon SL, Groves NB, Kofler MJ. Are emotion recognition abilities intact in pediatric ADHD?. Emotion 2019; 19 (07) 1192-1205
  • 123 Salum GA, Sergeant J, Sonuga-Barke E. , et al. Specificity of basic information processing and inhibitory control in attention deficit hyperactivity disorder. Psychol Med 2014; 44 (03) 617-631
  • 124 Nigg JT, Gustafsson HC, Karalunas SL. , et al. Working memory and vigilance as multivariate endophenotypes related to common genetic risk for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2018; 57 (03) 175-182
  • 125 Albrecht B, Brandeis D, Uebel-von Sandersleben H. , et al. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1. J Child Psychol Psychiatry 2014; 55 (08) 914-923
  • 126 Kebir O, Joober R. Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci 2011; 261 (08) 583-594
  • 127 Pinto R, Asherson P, Ilott N, Cheung CH, Kuntsi J. Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits. Am J Med Genet B Neuropsychiatr Genet 2016; 171 (07) 982-992
  • 128 Martin J, Hamshere ML, Stergiakouli E, O'Donovan MC, Thapar A. Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder. J Child Psychol Psychiatry 2015; 56 (06) 648-656
  • 129 Kamradt JM, Nigg JT, Friderici KH, Nikolas MA. Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: A multiple mediation analysis. Dev Psychopathol 2017; 29 (01) 259-272
  • 130 Sonuga-Barke EJ, Coghill D. The foundations of next generation attention-deficit/hyperactivity disorder neuropsychology: building on progress during the last 30 years. J Child Psychol Psychiatry 2014; 55 (12) e1-e5
  • 131 Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 2000; 24 (01) 7-12
  • 132 Tan A, Delgaty L, Steward K, Bunner M. Performance-based measures and behavioral ratings of executive function in diagnosing attention-deficit/hyperactivity disorder in children. Atten Defic Hyperact Disord 2018; 10 (04) 309-316
  • 133 Toplak ME, Bucciarelli SM, Jain U, Tannock R. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol 2009; 15 (01) 53-72
  • 134 Rommelse N, Antshel K, Smeets S. , et al. High intelligence and the risk of ADHD and other psychopathology. Br J Psychiatry 2017; 211 (06) 359-364
  • 135 Heidbreder R. ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis. Atten Defic Hyperact Disord 2015; 7 (04) 249-269
  • 136 Brandeis D, Loo S, McLoughlin G, Heinrich H, Banaschewski T. Neurophysiology. In: Banaschewski T, Coghill D, Zuddas A. , eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford: Oxford University Press; 2018: 82-93
  • 137 Buyck I, Wiersema JR. Resting electroencephalogram in attention deficit hyperactivity disorder: developmental course and diagnostic value. Psychiatry Res 2014; 216 (03) 391-397
  • 138 Liechti MD, Valko L, Müller UC. , et al. Diagnostic value of resting electroencephalogram in attention-deficit/hyperactivity disorder across the lifespan. Brain Topogr 2013; 26 (01) 135-151
  • 139 Clarke AR, Barry RJ, Dupuy FE. , et al. Behavioural differences between EEG-defined subgroups of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2011; 122 (07) 1333-1341
  • 140 Loo SK, Hale TS, Macion J. , et al. Cortical activity patterns in ADHD during arousal, activation and sustained attention. Neuropsychologia 2009; 47 (10) 2114-2119
  • 141 Loo SK, Cho A, Hale TS, McGough J, McCracken J, Smalley SL. Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J Atten Disord 2013; 17 (05) 384-392
  • 142 Poil SS, Bollmann S, Ghisleni C. , et al. Age dependent electroencephalographic changes in attention-deficit/hyperactivity disorder (ADHD). Clin Neurophysiol 2014; 125 (08) 1626-1638
  • 143 Arns M, Conners CK, Kraemer HC. A decade of EEG theta/beta ratio research in ADHD: a meta-analysis. J Atten Disord 2013; 17 (05) 374-383
  • 144 Zhang DW, Johnstone SJ, Li H. , et al. Time effects on resting EEG in children with/without ADHD. Brain Topogr 2019; 32 (02) 286-294
  • 145 Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 1999; 29 (2-3): 169-195
  • 146 Skirrow C, McLoughlin G, Banaschewski T, Brandeis D, Kuntsi J, Asherson P. Normalisation of frontal theta activity following methylphenidate treatment in adult attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2015; 25 (01) 85-94
  • 147 Ringli M, Souissi S, Kurth S, Brandeis D, Jenni OG, Huber R. Topography of sleep slow wave activity in children with attention-deficit/hyperactivity disorder. Cortex 2013; 49 (01) 340-347
  • 148 Doehnert M, Brandeis D, Imhof K, Drechsler R, Steinhausen HC. Mapping attention-deficit/hyperactivity disorder from childhood to adolescence--no neurophysiologic evidence for a developmental lag of attention but some for inhibition. Biol Psychiatry 2010; 67 (07) 608-616
  • 149 Shaw P, De Rossi P, Watson B. , et al. Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2014; 53 (07) 780-9.e11
  • 150 Barry RJ, Johnstone SJ, Clarke AR. A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clin Neurophysiol 2003; 114 (02) 184-198
  • 151 Albrecht B, Brandeis D, Uebel H. , et al. Familiality of neural preparation and response control in childhood attention deficit-hyperactivity disorder. Psychol Med 2013; 43 (09) 1997-2011
  • 152 McLoughlin G, Asherson P, Albrecht B. , et al. Cognitive-electrophysiological indices of attentional and inhibitory processing in adults with ADHD: familial effects. Behav Brain Funct 2011; 7: 26
  • 153 Cheung CH, Rijsdijk F, McLoughlin G. , et al. Cognitive and neurophysiological markers of ADHD persistence and remission. Br J Psychiatry 2016; 208 (06) 548-555
  • 154 Gamma A, Kara O. Event-related potentials for diagnosing children and adults with ADHD. J Atten Disord 2016; ; (e-pub ahead of print) DOI: 10.1177/1087054716631821.
  • 155 Snyder SM, Rugino TA, Hornig M, Stein MA. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain Behav 2015; 5 (04) e00330
  • 156 Arns M, Loo SK, Sterman MB. , et al. Editorial perspective: how should child psychologists and psychiatrists interpret FDA device approval? Caveat emptor. J Child Psychol Psychiatry 2016; 57 (05) 656-658
  • 157 Gloss D, Varma JK, Pringsheim T, Nuwer MR. Practice advisory: the utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2016; 87 (22) 2375-2379
  • 158 Mueller A, Candrian G, Grane VA, Kropotov JD, Ponomarev VA, Baschera GM. Discriminating between ADHD adults and controls using independent ERP components and a support vector machine: a validation study. Nonlinear Biomed Phys 2011; 5: 5
  • 159 Pulini AA, Kerr WT, Loo SK, Lenartowicz A. Classification accuracy of neuroimaging biomarkers in attention-deficit/hyperactivity disorder: effects of sample size and circular analysis. Biol Psychiatry Cogn Neurosci Neuroimaging 2019; 4 (02) 108-120
  • 160 Arns M, Vollebregt MA, Palmer D. , et al. Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2018; 28 (08) 881-891
  • 161 Wangler S, Gevensleben H, Albrecht B. , et al. Neurofeedback in children with ADHD: specific event-related potential findings of a randomized controlled trial. Clin Neurophysiol 2011; 122 (05) 942-950
  • 162 Giedd JN, Blumenthal J, Jeffries NO. , et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999; 2 (10) 861-863
  • 163 Gogtay N, Giedd JN, Lusk L. , et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004; 101 (21) 8174-8179
  • 164 Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci 2003; 6 (03) 309-315
  • 165 Sowell ER, Trauner DA, Gamst A, Jernigan TL. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev Med Child Neurol 2002; 44 (01) 4-16
  • 166 Shaw P, Eckstrand K, Sharp W. , et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 2007; 104 (49) 19649-19654
  • 167 Shaw P, Malek M, Watson B, Sharp W, Evans A, Greenstein D. Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol Psychiatry 2012; 72 (03) 191-197
  • 168 Ambrosino S, de Zeeuw P, Wierenga LM, van Dijk S, Durston S. What can cortical development in attention-deficit/hyperactivity disorder teach us about the early developmental mechanisms involved?. Cereb Cortex 2017; 27 (09) 4624-4634
  • 169 Hoogman M, Bralten J, Hibar DP. , et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 2017; 4 (04) 310-319
  • 170 Durston S, Hulshoff Pol HE, Schnack HG. , et al. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry 2004; 43 (03) 332-340
  • 171 Hoogman M, Rijpkema M, Janss L. , et al. Current self-reported symptoms of attention deficit/hyperactivity disorder are associated with total brain volume in healthy adults. PLoS One 2012; 7 (02) e31273
  • 172 Castellanos FX, Lee PP, Sharp W. , et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288 (14) 1740-1748
  • 173 Frodl T, Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 2012; 125 (02) 114-126
  • 174 Greven CU, Bralten J, Mennes M. , et al. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings. JAMA Psychiatry 2015; 72 (05) 490-499
  • 175 Huang-Pollock C, Ratcliff R, McKoon G, Shapiro Z, Weigard A, Galloway-Long H. Using the diffusion model to explain cognitive deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol 2017; 45 (01) 57-68
  • 176 Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry 2011; 168 (11) 1154-1163
  • 177 Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61 (12) 1361-1369
  • 178 Ducharme S, Hudziak JJ, Botteron KN. , et al; Brain Development Cooperative Group. Decreased regional cortical thickness and thinning rate are associated with inattention symptoms in healthy children. J Am Acad Child Adolesc Psychiatry 2012; 51 (01) 18-27.e2
  • 179 van Ewijk H, Heslenfeld DJ, Zwiers MP, Buitelaar JK, Oosterlaan J. Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev 2012; 36 (04) 1093-1106
  • 180 Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995; 34 (04) 537-541
  • 181 Posner J, Park C, Wang Z. Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder. Neuropsychol Rev 2014; 24 (01) 3-15
  • 182 Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008; 1124: 1-38
  • 183 Raichle ME, Snyder AZ. A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007; 37 (04) 1083-1090 , discussion 1097–1099
  • 184 Cao X, Cao Q, Long X. , et al. Abnormal resting-state functional connectivity patterns of the putamen in medication-naïve children with attention deficit hyperactivity disorder. Brain Res 2009; 1303: 195-206
  • 185 Castellanos FX, Margulies DS, Kelly C. , et al. Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2008; 63 (03) 332-337
  • 186 Sun L, Cao Q, Long X. , et al. Abnormal functional connectivity between the anterior cingulate and the default mode network in drug-naïve boys with attention deficit hyperactivity disorder. Psychiatry Res 2012; 201 (02) 120-127
  • 187 Bos DJ, Oranje B, Achterberg M. , et al. Structural and functional connectivity in children and adolescents with and without attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 2017; 58 (07) 810-818
  • 188 Cortese S, Kelly C, Chabernaud C. , et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 2012; 169 (10) 1038-1055
  • 189 Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 2006; 47 (10) 1051-1062
  • 190 Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013; 70 (02) 185-198
  • 191 Rubia K. “Cool” inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus “hot” ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review. Biol Psychiatry 2011; 69 (12) e69-e87
  • 192 Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005; 28 (03) 397-419 , discussion 419–468
  • 193 Sonuga-Barke EJ. Editorial: ADHD as a reinforcement disorder - moving from general effects to identifying (six) specific models to test. J Child Psychol Psychiatry 2011; 52 (09) 917-918
  • 194 Tripp G, Wickens JR. Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 2008; 49 (07) 691-704
  • 195 Plichta MM, Scheres A. Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature. Neurosci Biobehav Rev 2014; 38: 125-134
  • 196 Hauser TU, Iannaccone R, Ball J. , et al. Role of the medial prefrontal cortex in impaired decision making in juvenile attention-deficit/hyperactivity disorder. JAMA Psychiatry 2014; 71 (10) 1165-1173
  • 197 Scheres A, Milham MP, Knutson B, Castellanos FX. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61 (05) 720-724
  • 198 Aarts E, van Holstein M, Hoogman M. , et al. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine. Behav Pharmacol 2015; 26 (1,2): 227-240
  • 199 Baumeister S, Wolf I, Hohmann S. , et al. The impact of successful learning of self-regulation on reward processing in children with ADHD using fMRI. Atten Defic Hyperact Disord 2019; 11 (01) 31-45
  • 200 Baumeister S, Wolf I, Holz N. , et al. Neurofeedback training effects on inhibitory brain activation in ADHD: a matter of learning?. Neuroscience 2018; 378: 89-99
  • 201 Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task. Neuropharmacology 2009; 57 (7,8): 640-652
  • 202 Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry 2019; 24 (04) 562-575
  • 203 Larsson H, Chang Z, D'Onofrio BM, Lichtenstein P. The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan. Psychol Med 2014; 44 (10) 2223-2229
  • 204 Sudre G, Choudhuri S, Szekely E. , et al. Estimating the heritability of structural and functional brain connectivity in families affected by attention-deficit/hyperactivity disorder. JAMA Psychiatry 2017; 74 (01) 76-84
  • 205 Anokhin AP, Golosheykin S, Grant JD, Heath AC. Heritability of brain activity related to response inhibition: A longitudinal genetic study in adolescent twins. Int J Psychophysiol 2017; 115: 112-124
  • 206 Pappa I, Fedko IO, Mileva-Seitz VR. , et al. Single nucleotide polymorphism heritability of behavior problems in childhood: genome-wide complex trait analysis. J Am Acad Child Adolesc Psychiatry 2015; 54 (09) 737-744
  • 207 Greven CU, Merwood A, van der Meer JM, Haworth CM, Rommelse N, Buitelaar JK. The opposite end of the attention deficit hyperactivity disorder continuum: genetic and environmental aetiologies of extremely low ADHD traits. J Child Psychol Psychiatry 2016; 57 (04) 523-531
  • 208 Anttila V, Bulik-Sullivan B, Finucane HK. , et al; Brainstorm Consortium. Analysis of shared heritability in common disorders of the brain. Science 2018; 360 (6395): 360
  • 209 Taylor MJ, Martin J, Lu Y. , et al. Association of genetic risk factors for psychiatric disorders and traits of these disorders in a swedish population twin sample. JAMA Psychiatry 2019; 76 (03) 280-289
  • 210 Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009; 126 (01) 51-90
  • 211 Wu J, Xiao H, Sun H, Zou L, Zhu LQ. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol 2012; 45 (03) 605-620
  • 212 Anney RJ, Lasky-Su J, O'Dúshláine C. , et al. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet B Neuropsychiatr Genet 2008; 147B (08) 1369-1378
  • 213 Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet 2009; 126 (01) 13-50
  • 214 Hinney A, Scherag A, Jarick I. , et al; Psychiatric GWAS Consortium: ADHD subgroup. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156B (08) 888-897
  • 215 Lasky-Su J, Neale BM, Franke B. , et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 2008; 147B (08) 1345-1354
  • 216 Mick E, Todorov A, Smalley S. , et al. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49 (09) 898-905.e3
  • 217 Neale BM, Lasky-Su J, Anney R. , et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B (08) 1337-1344
  • 218 Neale BM, Medland S, Ripke S. , et al; IMAGE II Consortium Group. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49 (09) 906-920
  • 219 Neale BM, Medland SE, Ripke S. , et al; Psychiatric GWAS Consortium: ADHD Subgroup. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49 (09) 884-897
  • 220 Sánchez-Mora C, Ramos-Quiroga JA, Bosch R. , et al. Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. Neuropsychopharmacology 2015; 40 (04) 915-926
  • 221 Stergiakouli E, Hamshere M, Holmans P. , et al; deCODE Genetics, Psychiatric GWAS Consortium. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012; 169 (02) 186-194
  • 222 van Hulzen KJE, Scholz CJ, Franke B. , et al; PGC ADHD Working Group; PGC Bipolar Disorder Working Group. Genetic overlap between attention-deficit/hyperactivity disorder and bipolar disorder: evidence from genome-wide association study meta-analysis. Biol Psychiatry 2017; 82 (09) 634-641
  • 223 Yang L, Neale BM, Liu L. , et al; Psychiatric GWAS Consortium: ADHD Subgroup. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet 2013; 162B (05) 419-430
  • 224 Zayats T, Athanasiu L, Sonderby I. , et al. Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PLoS One 2015; 10 (04) e0122501
  • 225 Demontis D, Walters RK, Martin J. , et al; ADHD Working Group of the Psychiatric Genomics Consortium (PGC); Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium; 23andMe Research Team. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet 2019; 51 (01) 63-75
  • 226 Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD practice Guidelines. Fourth edition. 2018 Available at: https://www.caddra.ca/download-guidelines . Accessed February 18, 2019
  • 227 Pliszka S. AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46 (07) 894-921
  • 228 Taylor E, Döpfner M, Sergeant J. , et al. European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry 2004; 13 (Suppl. 01) I7-I30
  • 229 Döpfner M, Ise E, Breuer D, Rademacher C, Metternich-Kaizman TW, Schürmann S. Long-term course after adaptive multimodal treatment for children with ADHD: an 8-year follow-up. J Atten Disord 2016; ; (e-pub ahead of print) DOI: 10.1177/1087054716659138.
  • 230 Geissler J, Jans T, Banaschewski T. , et al. Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife. Trials 2018; 19 (01) 254
  • 231 Coates J, Taylor JA, Sayal K. Parenting interventions for ADHD: a systematic literature review and meta-analysis. J Atten Disord 2015; 19 (10) 831-843
  • 232 Daley D, Van Der Oord S, Ferrin M. , et al. Practitioner review: current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. J Child Psychol Psychiatry 2018; 59 (09) 932-947
  • 233 Tarver J, Daley D, Sayal K. Beyond symptom control for attention-deficit hyperactivity disorder (ADHD): what can parents do to improve outcomes?. Child Care Health Dev 2015; 41 (01) 1-14
  • 234 Robin AL. Family therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am 2014; 23 (04) 747-756
  • 235 DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am 2014; 23 (04) 687-697
  • 236 Moore DA, Richardson M, Gwernan-Jones R. , et al. Non-pharmacological interventions for ADHD in school settings: an overarching synthesis of systematic reviews. J Atten Disord 2019; 23 (03) 220-233
  • 237 Richardson M, Moore DA, Gwernan-Jones R. , et al. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research. Health Technol Assess 2015; 19 (45) 1-470
  • 238 Walitza S, Romanos M, Greenhill LL, Banaschewski T. Attention-Deficit/Hyperactivity Disorders. In: Gerlach M, Warnke A, Greenhill LL. , eds. Psychiatric Drugs in Children and Adolescents. Wien: Springer; 2014: 369-381
  • 239 Walitza S, Gerlach M, Romanos M, Renner T. Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden. In: Gerlach M, Mehler-Wex C, Walitza S, Warnke A, Wewetzer C. , eds. Neuro-/Psychopharmaka im Kindes- und Jugendalter: Grundlagen und Therapie. Berlin, Heidelberg: Springer Berlin Heidelberg; 2016: 289-331
  • 240 The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56 (12) 1073-1086
  • 241 MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56 (12) 1088-1096
  • 242 MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113 (04) 754-761
  • 243 Banaschewski T, Soutullo C, Lecendreux M. , et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs 2013; 27 (10) 829-840
  • 244 Coghill DR, Banaschewski T, Lecendreux M. , et al. Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial. Eur Child Adolesc Psychiatry 2014; 23 (02) 61-68
  • 245 Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present--a pharmacological and clinical perspective. J Psychopharmacol 2013; 27 (06) 479-496
  • 246 Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol 2013; 23 (05) 308-319
  • 247 Storebø OJ, Ramstad E, Krogh HB. , et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2015; (11) CD009885
  • 248 Döpfner M, Ise E, Wolff Metternich-Kaizman T, Schürmann S, Rademacher C, Breuer D. Adaptive multimodal treatment for children with attention-deficit-/hyperactivity disorder: an 18 month follow-up. Child Psychiatry Hum Dev 2015; 46 (01) 44-56
  • 249 Daley D, van der Oord S, Ferrin M. , et al; European ADHD Guidelines Group. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry 2014; 53 (08) 835-847 , 847.e1–847.e5
  • 250 Sonuga-Barke EJ, Brandeis D, Cortese S. , et al; European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013; 170 (03) 275-289
  • 251 Ding Q, Li M, Zhu D. Is combined CBT therapy more effective than drug therapy alone for ADHD in children? A meta-analysis. Traditional Medicine and Modern Medicine 2018; 01: 21-26
  • 252 Bikic A, Leckman JF, Christensen TO, Bilenberg N, Dalsgaard S. Attention and executive functions computer training for attention-deficit/hyperactivity disorder (ADHD): results from a randomized, controlled trial. Eur Child Adolesc Psychiatry 2018; 27 (12) 1563-1574
  • 253 Cortese S, Ferrin M, Brandeis D. , et al; European ADHD Guidelines Group (EAGG). Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry 2015; 54 (03) 164-174
  • 254 Loo SK, McGough JJ, McCracken JT, Smalley SL. Parsing heterogeneity in attention-deficit hyperactivity disorder using EEG-based subgroups. J Child Psychol Psychiatry 2018; 59 (03) 223-231
  • 255 Cortese S, Ferrin M, Brandeis D. , et al; European ADHD Guidelines Group (EAGG). Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry 2016; 55 (06) 444-455
  • 256 Zuberer A, Brandeis D, Drechsler R. Are treatment effects of neurofeedback training in children with ADHD related to the successful regulation of brain activity? A review on the learning of regulation of brain activity and a contribution to the discussion on specificity. Front Hum Neurosci 2015; 9: 135
  • 257 Liechti MD, Maurizio S, Heinrich H. , et al. First clinical trial of tomographic neurofeedback in attention-deficit/hyperactivity disorder: evaluation of voluntary cortical control. Clin Neurophysiol 2012; 123 (10) 1989-2005
  • 258 Rubia K. Cognitive neuroscience of attention deficit hyperactivity disorder (ADHD) and its clinical translation. Front Hum Neurosci 2018; 12: 100
  • 259 Marx AM, Ehlis AC, Furdea A. , et al. Near-infrared spectroscopy (NIRS) neurofeedback as a treatment for children with attention deficit hyperactivity disorder (ADHD)-a pilot study. Front Hum Neurosci 2015; 8: 1038
  • 260 Doruk Camsari D, Kirkovski M, Croarkin PE. Therapeutic applications of noninvasive neuromodulation in children and adolescents. Psychiatr Clin North Am 2018; 41 (03) 465-477
  • 261 Lee JC, Kenney-Jung DL, Blacker CJ, Doruk Camsari D, Lewis CP. Transcranial direct current stimulation in child and adolescent psychiatric disorders. Child Adolesc Psychiatr Clin N Am 2019; 28 (01) 61-78
  • 262 Rubio B, Boes AD, Laganiere S, Rotenberg A, Jeurissen D, Pascual-Leone A. Noninvasive brain stimulation in pediatric attention-deficit hyperactivity disorder (ADHD): a review. J Child Neurol 2016; 31 (06) 784-796
  • 263 Westwood S, Radua J, Rubia K. Non-invasive brain stimulation as an alternative treatment for ADHD: a systematic review and meta-analysis. Brain Stimulation. Basic, Translational, and Clinical Research in Neuromodulation 2019; 12: 502
  • 264 Cairncross M, Miller CJ. The effectiveness of mindfulness-based therapies for ADHD: a meta-analytic review. J Atten Disord 2016; ; (e-pub ahead of print) DOI: 10.1177/1087054715625301.
  • 265 Cerrillo-Urbina AJ, García-Hermoso A, Sánchez-López M, Pardo-Guijarro MJ, Santos Gómez JL, Martínez-Vizcaíno V. The effects of physical exercise in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis of randomized control trials. Child Care Health Dev 2015; 41 (06) 779-788
  • 266 Evans S, Ling M, Hill B, Rinehart N, Austin D, Sciberras E. Systematic review of meditation-based interventions for children with ADHD. Eur Child Adolesc Psychiatry 2018; 27 (01) 9-27
  • 267 Krisanaprakornkit T, Ngamjarus C, Witoonchart C, Piyavhatkul N. Meditation therapies for attention-deficit/hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2010; (06) CD006507
  • 268 S J, Arumugam N, Parasher RK. Effect of physical exercises on attention, motor skill and physical fitness in children with attention deficit hyperactivity disorder: a systematic review. Atten Defic Hyperact Disord 2019; 11 (02) 125-137
  • 269 Hollis C, Falconer CJ, Martin JL. , et al. Annual research review: digital health interventions for children and young people with mental health problems - a systematic and meta-review. J Child Psychol Psychiatry 2017; 58 (04) 474-503
  • 270 Powell L, Parker J, Harpin V. ADHD: is there an app for that? A suitability assessment of apps for the parents of children and young people with ADHD. JMIR Mhealth Uhealth 2017; 5 (10) e149
  • 271 Kietglaiwansiri T, Chonchaiya W. Pattern of video game use in children with attention-deficit-hyperactivity disorder and typical development. Pediatr Int (Roma) 2018; 60 (06) 523-528
  • 272 Gau SS, Chang JP. Maternal parenting styles and mother-child relationship among adolescents with and without persistent attention-deficit/hyperactivity disorder. Res Dev Disabil 2013; 34 (05) 1581-1594
  • 273 Steinhausen HC, Drechsler R, Foldenyi M, Imhof K, Brandeis D. Clinical course of attention-deficit/hyperactivity disorder from childhood toward early adolescence. J Am Acad Child Adolesc Psychiatry 2003; 42 (09) 1085-1092
  • 274 Sudre G, Mangalmurti A, Shaw P. Growing out of attention deficit hyperactivity disorder: Insights from the ‘remitted’ brain. Neurosci Biobehav Rev 2018; 94: 198-209
  • 275 Agnew-Blais JC, Polanczyk GV, Danese A, Wertz J, Moffitt TE, Arseneault L. Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry 2016; 73 (07) 713-720
  • 276 Caye A, Rocha TB, Anselmi L. , et al. Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry 2016; 73 (07) 705-712
  • 277 Moffitt TE, Houts R, Asherson P. , et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 2015; 172 (10) 967-977
  • 278 Cooper M, Hammerton G, Collishaw S. , et al. Investigating late-onset ADHD: a population cohort investigation. J Child Psychol Psychiatry 2018; 59 (10) 1105-1113
  • 279 Sibley MH, Rohde LA, Swanson JM. , et al; Multimodal Treatment Study of Children with ADHD (MTA) Cooperative Group. Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25. Am J Psychiatry 2018; 175 (02) 140-149
  • 280 Bonvicini C, Faraone SV, Scassellati C. Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry 2018; 19 (02) 80-100
  • 281 Swanson JM, Arnold LE, Jensen PE. , et al. Longterm outcomes in the Multimodal treatment study of children with ADHD (the MTA): From beginning to the End. In: Banaschewski T, Coghill D, Zuddas A. , eds. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford: Oxford University Press; 2018: 315-332